首页 > 最新文献

Journal of infectious diseases and epidemiology最新文献

英文 中文
Molecular patterns of neurodegeneration in coronavirus infection caused by SARS-CoV-2 SARS-CoV-2引起的冠状病毒感染中神经变性的分子模式
Pub Date : 2023-06-30 DOI: 10.17816/eid326205
A. O. Mikhailov, N. Plekhova, S. Sokotun, A. Simakova, A. S. Bedareva
BACKGROUND: The reports on the neurological and psychiatric consequences of coronavirus infection are of particular relevance owing to their limited availability. The molecular patterns of nerve tissue damage are an important task for understanding the underlying mechanisms of neurodegeneration. AIM: To study the dynamics of changes in the content of markers of neurodegeneration and neuroplasticity in patients with coronavirus infection in the acute and long-term periods. MATERIALS AND METHODS: A total of 200 patients aged 5183 years were assessed and categorized into two age groups: 5165 years and 6683 years. The levels of neurodegeneration markers were determined in the blood serum: neurofilament heavy chains (NEFH), S100 A6 protein, S100 B protein, -amyloid 1-42 (A1-42), microfilament associated tau protein (MAPt), serum amyloid P (SAP), and neuroplasticity: neurotrophin 3 (NT3), neurotrophin 4 (NT4). The study was performed thrice in the acute period of the disease at the time of admission to the hospital and at 6 and 12 months after discharge. RESULTS: In the first group of patients, in the acute period of coronavirus infection, women showed higher concentrations of S100 A6 (3.20.2), S100 B (0.40.06), NT3 (1.10.1), and MAPt (0.130.02), while the values for the men were NEFH (0.150.03), A1-42 (2.10.1), and SAP (4.50.06). In the long-term, a general tendency of long persistence of high levels of the markers of neurodegeneration and neuroprotection was noted in young men compared to women, indicating a long period of rehabilitation. After 12 months, the level of calcium-binding proteins S100 A6 and S100 B in men was 1.50.2 pg/mL and 0.30.04 ng/mL, which was 1.10.1 pg/mL and 0.20.04 ng/mL, respectively, in women. The level of SAP in men during the long-term period after 12 months was 4.30.1 versus 3.90.2 ng/mL in women, indicating a significant difference. Analyses of the results for the patients in the second group indicated a higher level of S100 A6 and A1-42 in the acute period for women, while men showed higher levels of S100 B, NT3, and SAP. CONCLUSION: The changes in patients with coronavirus infection both in the acute and late periods indicated active neurodegeneration processes in different age groups, which manifested as a result of an increase in the concentration of specific proteins in the blood serum.
背景:关于冠状病毒感染的神经和精神后果的报告由于其有限的可用性而具有特别的相关性。神经组织损伤的分子模式是理解神经退行性变潜在机制的重要任务。目的:研究冠状病毒感染患者急性期和长期神经变性和神经可塑性标志物含量的变化动态。材料与方法:共200例5183岁的患者被评估并分为两个年龄组:5165岁和6683岁。测定血清中神经变性标志物的水平:神经丝重链(NEFH)、S100 A6蛋白、S100 B蛋白、-淀粉样蛋白1-42 (A1-42)、微丝相关tau蛋白(MAPt)、血清淀粉样蛋白P (SAP)和神经可塑性:神经营养因子3 (NT3)、神经营养因子4 (NT4)。该研究在入院时疾病的急性期和出院后6个月和12个月进行了三次。结果:第一组患者在冠状病毒感染急性期,女性患者S100 A6(3.20.2)、S100 B(0.40.06)、NT3(1.10.1)、MAPt(0.130.02)浓度较高,男性患者NEFH(0.150.03)、A1-42(2.10.1)、SAP(4.50.06)浓度较高。从长期来看,与女性相比,年轻男性的神经退行性变和神经保护标志物长期持续高水平的总体趋势,表明康复期较长。12个月后,男性的钙结合蛋白S100 A6和S100 B水平分别为1.50.2 pg/mL和0.30.04 ng/mL,女性分别为1.10.1 pg/mL和0.20.04 ng/mL。12个月后,男性的SAP水平为4.30.1,女性为3.90.2 ng/mL,差异有统计学意义。第二组患者急性期S100 A6、A1-42水平较高,男性患者急性期S100 B、NT3、SAP水平较高。结论:冠状病毒感染患者急性期和晚期的变化表明不同年龄组的神经退行性变过程活跃,表现为血清中特异性蛋白浓度升高。
{"title":"Molecular patterns of neurodegeneration in coronavirus infection caused by SARS-CoV-2","authors":"A. O. Mikhailov, N. Plekhova, S. Sokotun, A. Simakova, A. S. Bedareva","doi":"10.17816/eid326205","DOIUrl":"https://doi.org/10.17816/eid326205","url":null,"abstract":"BACKGROUND: The reports on the neurological and psychiatric consequences of coronavirus infection are of particular relevance owing to their limited availability. The molecular patterns of nerve tissue damage are an important task for understanding the underlying mechanisms of neurodegeneration. \u0000AIM: To study the dynamics of changes in the content of markers of neurodegeneration and neuroplasticity in patients with coronavirus infection in the acute and long-term periods. \u0000MATERIALS AND METHODS: A total of 200 patients aged 5183 years were assessed and categorized into two age groups: 5165 years and 6683 years. The levels of neurodegeneration markers were determined in the blood serum: neurofilament heavy chains (NEFH), S100 A6 protein, S100 B protein, -amyloid 1-42 (A1-42), microfilament associated tau protein (MAPt), serum amyloid P (SAP), and neuroplasticity: neurotrophin 3 (NT3), neurotrophin 4 (NT4). The study was performed thrice in the acute period of the disease at the time of admission to the hospital and at 6 and 12 months after discharge. \u0000RESULTS: In the first group of patients, in the acute period of coronavirus infection, women showed higher concentrations of S100 A6 (3.20.2), S100 B (0.40.06), NT3 (1.10.1), and MAPt (0.130.02), while the values for the men were NEFH (0.150.03), A1-42 (2.10.1), and SAP (4.50.06). In the long-term, a general tendency of long persistence of high levels of the markers of neurodegeneration and neuroprotection was noted in young men compared to women, indicating a long period of rehabilitation. After 12 months, the level of calcium-binding proteins S100 A6 and S100 B in men was 1.50.2 pg/mL and 0.30.04 ng/mL, which was 1.10.1 pg/mL and 0.20.04 ng/mL, respectively, in women. The level of SAP in men during the long-term period after 12 months was 4.30.1 versus 3.90.2 ng/mL in women, indicating a significant difference. \u0000Analyses of the results for the patients in the second group indicated a higher level of S100 A6 and A1-42 in the acute period for women, while men showed higher levels of S100 B, NT3, and SAP. \u0000CONCLUSION: The changes in patients with coronavirus infection both in the acute and late periods indicated active neurodegeneration processes in different age groups, which manifested as a result of an increase in the concentration of specific proteins in the blood serum.","PeriodicalId":93465,"journal":{"name":"Journal of infectious diseases and epidemiology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87967819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of microbiome in development of systemic inflammatory response syndrome and sepsis (review) 微生物组在全身性炎症反应综合征和败血症发展中的作用(综述)
Pub Date : 2023-06-30 DOI: 10.17816/eid451025
T. I. Khomyakova, Yuri N. Khomyakov, O. Makarova
Sepsis is a life-threatening organ dysfunction caused by a disturbed response to infection. Its development is preceded by systemic inflammatory response syndrome, which is the overall inflammatory response of the body to severe lesions. The role of opportunistic pathogens in the development of systemic inflammatory response syndrome and sepsis may be known, but the value of the intestinal microbiome remains underestimated in this context. Experimental models are widely employed to study the role of the microbiome in the development of sepsis. Animal models of sepsis are created by disrupting the barrier function of the host intestine through cecal ligation/puncture, installation of an ascending bowel stent, and intraperitoneal feces injection. Toxemia is reproduced by the injection of lipopolysaccharides, peptidoglycans, lipoteichoic acid, CpG DNA, zymosan, and synthetic lipopeptides. The review systematized data on the role of the cell wall or membrane components of gram-positive and gram-negative bacteria, which are representatives of the intestinal microbiome in the pathogenesis of systemic inflammatory response syndrome and sepsis.
败血症是一种危及生命的器官功能障碍,由对感染的反应紊乱引起。它的发展之前是全身性炎症反应综合征,这是身体对严重病变的整体炎症反应。机会致病菌在全身性炎症反应综合征和败血症发展中的作用可能是已知的,但在这种情况下,肠道微生物组的价值仍然被低估。实验模型被广泛用于研究微生物组在脓毒症发展中的作用。脓毒症的动物模型是通过盲肠结扎/穿刺、安装升肠支架和腹腔内粪便注射来破坏宿主肠的屏障功能。毒血症可通过注射脂多糖、肽聚糖、脂质胆酸、CpG DNA、酶酶和合成脂肽而重现。该综述系统整理了革兰氏阳性菌和革兰氏阴性菌的细胞壁或膜组分在全身性炎症反应综合征和败血症发病机制中的作用,这些细菌是肠道微生物组的代表。
{"title":"Role of microbiome in development of systemic inflammatory response syndrome and sepsis (review)","authors":"T. I. Khomyakova, Yuri N. Khomyakov, O. Makarova","doi":"10.17816/eid451025","DOIUrl":"https://doi.org/10.17816/eid451025","url":null,"abstract":"Sepsis is a life-threatening organ dysfunction caused by a disturbed response to infection. Its development is preceded by systemic inflammatory response syndrome, which is the overall inflammatory response of the body to severe lesions. The role of opportunistic pathogens in the development of systemic inflammatory response syndrome and sepsis may be known, but the value of the intestinal microbiome remains underestimated in this context. \u0000Experimental models are widely employed to study the role of the microbiome in the development of sepsis. Animal models of sepsis are created by disrupting the barrier function of the host intestine through cecal ligation/puncture, installation of an ascending bowel stent, and intraperitoneal feces injection. Toxemia is reproduced by the injection of lipopolysaccharides, peptidoglycans, lipoteichoic acid, CpG DNA, zymosan, and synthetic lipopeptides. \u0000The review systematized data on the role of the cell wall or membrane components of gram-positive and gram-negative bacteria, which are representatives of the intestinal microbiome in the pathogenesis of systemic inflammatory response syndrome and sepsis.","PeriodicalId":93465,"journal":{"name":"Journal of infectious diseases and epidemiology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79101719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coping with the Ongoing SARS-CoV-2 Pandemic and Seasonal Influenza 应对持续的严重急性呼吸系统综合征冠状病毒2型大流行和季节性流感
Pub Date : 2023-05-31 DOI: 10.23937/2474-3658/1510304
Mustafa Mujahed I, Mohammed Ahmed
The ongoing SARS-COV-2 pandemic has brought about unprecedented challenges to individuals, communities, and healthcare systems worldwide. As the world braces for a potential second wave of COVID-19 infections, the seasonal influenza season is also looming. This article explores the coping strategies that individuals and healthcare systems can adopt to manage both the SARS-COV-2 pandemic and seasonal influenza. The article highlights the importance of vaccination, social distancing measures, and personal protective equipment in preventing the spread of both viruses. Additionally, it discusses the need for mental health support for individuals who are struggling to cope with the stressors brought about by these pandemics. The article concludes by emphasizing that a coordinated effort between individuals, communities, and healthcare systems is crucial in mitigating the impact of these pandemics on public health.
持续的严重急性呼吸系统综合征冠状病毒2型疫情给世界各地的个人、社区和医疗系统带来了前所未有的挑战。随着世界为潜在的第二波新冠肺炎感染做好准备,季节性流感季节也即将来临。本文探讨了个人和医疗系统可以采取的应对策略,以应对严重急性呼吸系统综合征冠状病毒2型大流行和季节性流感。这篇文章强调了疫苗接种、保持社交距离措施和个人防护设备在防止这两种病毒传播方面的重要性。此外,它还讨论了为那些正在努力应对这些流行病带来的压力的个人提供心理健康支持的必要性。文章最后强调,个人、社区和医疗系统之间的协调努力对于减轻这些流行病对公共卫生的影响至关重要。
{"title":"Coping with the Ongoing SARS-CoV-2 Pandemic and Seasonal Influenza","authors":"Mustafa Mujahed I, Mohammed Ahmed","doi":"10.23937/2474-3658/1510304","DOIUrl":"https://doi.org/10.23937/2474-3658/1510304","url":null,"abstract":"The ongoing SARS-COV-2 pandemic has brought about unprecedented challenges to individuals, communities, and healthcare systems worldwide. As the world braces for a potential second wave of COVID-19 infections, the seasonal influenza season is also looming. This article explores the coping strategies that individuals and healthcare systems can adopt to manage both the SARS-COV-2 pandemic and seasonal influenza. The article highlights the importance of vaccination, social distancing measures, and personal protective equipment in preventing the spread of both viruses. Additionally, it discusses the need for mental health support for individuals who are struggling to cope with the stressors brought about by these pandemics. The article concludes by emphasizing that a coordinated effort between individuals, communities, and healthcare systems is crucial in mitigating the impact of these pandemics on public health.","PeriodicalId":93465,"journal":{"name":"Journal of infectious diseases and epidemiology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44985173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
EPIDEMIC SEASON 2021-2022. FREQUENCY OF CO-INFECTION BY RESPIRATORY VIRAL PATHOGENS 2021-2022年流行季。呼吸道病毒病原体共同感染的频率
Pub Date : 2023-05-16 DOI: 10.17816/eid321873
E. Burtseva, A. D. Panova, L. Kolobukhina, A. V. Ignatjeva, E. Kirillova, N. V. Breslav, S. Trushakova, E. Mukasheva, E. L. Feodoritova, K. Krasnoslobodtsev, L. N. Merkulova, I. N. Khlopova, L. Kisteneva, I. Kruzhkova, Yu. S. Levochkina, Anastasia S. Krepkaia, Aleksandra G. Rosatkevich, A. Komissarov, Svetlana B. Yatsishina, Andrey A. Pochtovyi, D. D. Kustova, V. V. Gushchin, M. Bazarova, S. Smetanina, N. Tsvetkova
Introduction. The main purpose of this work was to determine the characteristics of the circulation of various viral respiratory pathogens during the epidemic season 2021-2022, as well as the frequency of co-infection against the background of SARS-CoV-2 and influenza. Materials and methods. The article uses methods of "traditional" and "hospital" epidemiological surveillance for acute respiratory viral infections. Results and discussion. The epidemic season of 2021-2022 was characterized by the early activity of the influenza A(H3N2) virus, as well as the appearance and rapid spread of a new variant of SARS-CoV-2 (omicron). The dependence on the share of different respiratory pathogens during the epidemic season 2021-2022 was clearly traced: the dominant role belonged to SARS-CoV-2 (18.8%), then to influenza viruses (10.6%) and, finally, to pathogens of other acute respiratory viral infections (0.4%-3.7%). With respect to influenza A(H3N2) and B viruses, heterogeneity of their populations and drift-variability in relation to vaccine strains were noted. The frequency of co-infection with various respiratory pathogens was low: according to "traditional surveillance" - no more than 0.1%, "hospital surveillance" no more than 9.2%. The rationale for updating the composition of influenza vaccines for the countries of the Northern Hemisphere for 2022-2023 season was given.
介绍。本工作的主要目的是在SARS-CoV-2和流感背景下,确定2021-2022年流行季节各种病毒性呼吸道病原体的传播特征,以及合并感染的频率。材料和方法。本文采用“传统”和“医院”两种流行病学监测方法对急性呼吸道病毒感染进行监测。结果和讨论。2021-2022年流行季的特点是甲型流感(H3N2)病毒的早期活动,以及新变种SARS-CoV-2(组粒)的出现和迅速传播。在2021-2022年流行季节,不同呼吸道病原体对感染份额的依赖性明显:SARS-CoV-2占主导地位(18.8%),其次是流感病毒(10.6%),最后是其他急性呼吸道病毒感染病原体(0.4%-3.7%)。关于甲型流感(H3N2)和乙型流感病毒,注意到其种群的异质性和与疫苗株相关的漂移变异性。各种呼吸道病原体合并感染的频率较低:根据“传统监测”-不超过0.1%,“医院监测”不超过9.2%。提出了更新2022-2023年北半球国家流感疫苗组成的理由。
{"title":"EPIDEMIC SEASON 2021-2022. FREQUENCY OF CO-INFECTION BY \u0000RESPIRATORY VIRAL PATHOGENS","authors":"E. Burtseva, A. D. Panova, L. Kolobukhina, A. V. Ignatjeva, E. Kirillova, N. V. Breslav, S. Trushakova, E. Mukasheva, E. L. Feodoritova, K. Krasnoslobodtsev, L. N. Merkulova, I. N. Khlopova, L. Kisteneva, I. Kruzhkova, Yu. S. Levochkina, Anastasia S. Krepkaia, Aleksandra G. Rosatkevich, A. Komissarov, Svetlana B. Yatsishina, Andrey A. Pochtovyi, D. D. Kustova, V. V. Gushchin, M. Bazarova, S. Smetanina, N. Tsvetkova","doi":"10.17816/eid321873","DOIUrl":"https://doi.org/10.17816/eid321873","url":null,"abstract":"Introduction. The main purpose of this work was to determine the characteristics of the circulation of various viral respiratory pathogens during the epidemic season 2021-2022, as well as the frequency of co-infection against the background of SARS-CoV-2 and influenza. \u0000Materials and methods. The article uses methods of \"traditional\" and \"hospital\" epidemiological surveillance for acute respiratory viral infections. \u0000Results and discussion. The epidemic season of 2021-2022 was characterized by the early activity of the influenza A(H3N2) virus, as well as the appearance and rapid spread of a new variant of SARS-CoV-2 (omicron). The dependence on the share of different respiratory pathogens during the epidemic season 2021-2022 was clearly traced: the dominant role belonged to SARS-CoV-2 (18.8%), then to influenza viruses (10.6%) and, finally, to pathogens of other acute respiratory viral infections (0.4%-3.7%). With respect to influenza A(H3N2) and B viruses, heterogeneity of their populations and drift-variability in relation to vaccine strains were noted. The frequency of co-infection with various respiratory pathogens was low: according to \"traditional surveillance\" - no more than 0.1%, \"hospital surveillance\" no more than 9.2%. The rationale for updating the composition of influenza vaccines for the countries of the Northern Hemisphere for 2022-2023 season was given.","PeriodicalId":93465,"journal":{"name":"Journal of infectious diseases and epidemiology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78234264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ANTIBACTERIAL MICROCINES, CLASS II (LITERATURE REVIEW) 抗菌微药,ii类(文献综述)
Pub Date : 2023-05-15 DOI: 10.17816/eid321851
A. Mironov
The issue of the use in medicine of effective antibacterial substances active against drug-resistant microorganisms remains relevant. Most publications on microcins show undoubted prospects for the further development of these numerous pharmacological agents of bacterial origin with multidirectional action (antibacterial, antiviral, antitumor, etc.). One of the features of the properties of microcins is their specific inhibitory activity against gram-negative microorganisms (first of all, Escherichia, as well as proteus, salmonella, pseudomonas, etc.). This review is compiled with the aim of briefly summarizing current information about one of the groups of microcins (class II) to assess their possible use in practical medicine and in scientific research. The review uses links from the RSCI, Web of Science, Scopus, PubMed databases.
在医学中使用对耐药微生物有效的抗菌物质的问题仍然是相关的。大多数关于微霉素的出版物显示,这些细菌来源的具有多向作用(抗菌、抗病毒、抗肿瘤等)的众多药理学药物无疑具有进一步发展的前景。微霉素的特性之一是其对革兰氏阴性微生物(首先是埃希氏菌,以及变形杆菌、沙门氏菌、假单胞菌等)的特异性抑制活性。编写这篇综述的目的是简要总结目前关于一类微霉素(II类)的信息,以评估它们在实际医学和科学研究中的可能应用。这篇综述使用了来自RSCI、Web of Science、Scopus、PubMed等数据库的链接。
{"title":"ANTIBACTERIAL MICROCINES, CLASS II (LITERATURE REVIEW)","authors":"A. Mironov","doi":"10.17816/eid321851","DOIUrl":"https://doi.org/10.17816/eid321851","url":null,"abstract":"The issue of the use in medicine of effective antibacterial substances active against drug-resistant microorganisms remains relevant. Most publications on microcins show undoubted prospects for the further development of these numerous pharmacological agents of bacterial origin with multidirectional action (antibacterial, antiviral, antitumor, etc.). One of the features of the properties of microcins is their specific inhibitory activity against gram-negative microorganisms (first of all, Escherichia, as well as proteus, salmonella, pseudomonas, etc.). This review is compiled with the aim of briefly summarizing current information about one of the groups of microcins (class II) to assess their possible use in practical medicine and in scientific research. The review uses links from the RSCI, Web of Science, Scopus, PubMed databases.","PeriodicalId":93465,"journal":{"name":"Journal of infectious diseases and epidemiology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90656826","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Retrospective Study Comparing CRB-65, MEWS and qSOFA Scoring System in Predicting Clinical Outcomes in Adult Patients with Severe and Critical COVID-19 Infection 比较CRB-65、MEWS和qSOFA评分系统预测成年重症和危重新冠肺炎感染患者临床结果的回顾性研究
Pub Date : 2023-04-30 DOI: 10.23937/2474-3658/1510300
Bautista Rafael Jeric C, Matti Pamela Rose
{"title":"A Retrospective Study Comparing CRB-65, MEWS and qSOFA Scoring System in Predicting Clinical Outcomes in Adult Patients with Severe and Critical COVID-19 Infection","authors":"Bautista Rafael Jeric C, Matti Pamela Rose","doi":"10.23937/2474-3658/1510300","DOIUrl":"https://doi.org/10.23937/2474-3658/1510300","url":null,"abstract":"","PeriodicalId":93465,"journal":{"name":"Journal of infectious diseases and epidemiology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48630621","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current Strategies to Improve Efficiency of Recombinant Subunit Vaccines 提高重组亚单位疫苗效率的当前策略
Pub Date : 2023-04-30 DOI: 10.23937/2474-3658/1510299
Aslanbay Guler Bahar, Imamoglu Esra
Global population growth and rising health concerns have highlighted the importance of developing effective vaccination strategies, and subunit vaccines hold great promise for meeting market demand. Compared to traditional whole-cell vaccines, subunit vaccines contain only a part of the infectious microorganism to induce an immune response against the main pathogen. Recent advances in molecular biology have paved the way for the development of recombinant subunit vaccines to provide ideal vaccination strategies. The production of these vaccines is a multi-step process in which each stage should be thoroughly evaluated with the goal of improving vaccine efficiency while remaining cost-effective. In this review, different approaches used for the improvement of recombinant subunit vaccines are described, considering production steps and vaccine formulations. Firstly, a brief summary is presented about different types of vaccines, especially recombinant subunit vaccines, and then several strategies, including novel expression systems, the selection of suitable adjuvants, and the integration of nanotechnology into the vaccine formulations are detailed in the light of the most recent progress. This article highlights the critical aspects of the development of more effective recombinant subunit vaccines with broad-spectrum protection
全球人口增长和日益严重的健康问题突出了制定有效的疫苗接种战略的重要性,亚单位疫苗在满足市场需求方面大有希望。与传统的全细胞疫苗相比,亚单位疫苗只含有一部分感染微生物,以诱导对主要病原体的免疫反应。分子生物学的最新进展为重组亚单位疫苗的发展铺平了道路,提供了理想的疫苗接种策略。这些疫苗的生产是一个多步骤过程,每个阶段都应进行彻底评估,目的是在保持成本效益的同时提高疫苗效率。在这篇综述中,考虑到生产步骤和疫苗配方,描述了用于改进重组亚单位疫苗的不同方法。首先简要介绍了不同类型的疫苗,特别是重组亚单位疫苗,然后根据最新进展详细介绍了几种策略,包括新的表达系统,合适佐剂的选择以及纳米技术与疫苗配方的结合。这篇文章强调了开发更有效的重组亚单位疫苗与广谱保护的关键方面
{"title":"Current Strategies to Improve Efficiency of Recombinant Subunit Vaccines","authors":"Aslanbay Guler Bahar, Imamoglu Esra","doi":"10.23937/2474-3658/1510299","DOIUrl":"https://doi.org/10.23937/2474-3658/1510299","url":null,"abstract":"Global population growth and rising health concerns have highlighted the importance of developing effective vaccination strategies, and subunit vaccines hold great promise for meeting market demand. Compared to traditional whole-cell vaccines, subunit vaccines contain only a part of the infectious microorganism to induce an immune response against the main pathogen. Recent advances in molecular biology have paved the way for the development of recombinant subunit vaccines to provide ideal vaccination strategies. The production of these vaccines is a multi-step process in which each stage should be thoroughly evaluated with the goal of improving vaccine efficiency while remaining cost-effective. In this review, different approaches used for the improvement of recombinant subunit vaccines are described, considering production steps and vaccine formulations. Firstly, a brief summary is presented about different types of vaccines, especially recombinant subunit vaccines, and then several strategies, including novel expression systems, the selection of suitable adjuvants, and the integration of nanotechnology into the vaccine formulations are detailed in the light of the most recent progress. This article highlights the critical aspects of the development of more effective recombinant subunit vaccines with broad-spectrum protection","PeriodicalId":93465,"journal":{"name":"Journal of infectious diseases and epidemiology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68753988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Molecular bases of the interaction of M. tuberculosis complex and anti-tuberculosis drugs: the current state of the problem and its epidemiological significance 结核分枝杆菌复合体与抗结核药物相互作用的分子基础:问题现状及其流行病学意义
Pub Date : 2023-04-12 DOI: 10.17816/eid312900
Yu. S. Khomyakov, D. D. Zvyagintseva, T. Khomyakova
According to the WHO Global Tuberculosis Report, published in 2022, tuberculosis and its drug-resistant forms are on the rise for the first time in lasted years. The ability to become immune to anti-tuberculosis drugs is a fundamental feature of the TB agent. In some cases, it develops a transient resistance to antibacterial drugs based on a combination of adaptive biological properties of mycobacterium without altering the genetic apparatus. This phenomenon is called drug-induced tolerance. Its development is associated with the slowing or altering of bacterial metabolism, increasing the thickness of the cell wall, activation of specific molecular pumps, removing medicinal substances from the cell outside the cell. The same and some other mechanisms are involved in the development of another phenomenon - drug resistance, which is associated with inherited changes in the genetic apparatus of mycobacterium. The review is devoted to the consideration of the molecular bases of mycobacterium tuberculosis interaction with anti-tuberculosis drugs and its epidemiological significance.
根据世卫组织2022年发布的《全球结核病报告》,结核病及其耐药形式多年来首次出现上升趋势。对抗结核药物产生免疫的能力是结核病药物的一个基本特征。在某些情况下,它在不改变遗传装置的情况下,基于分枝杆菌的适应性生物学特性的组合,对抗菌药物产生短暂的耐药性。这种现象被称为药物诱导耐受性。它的发展与细菌代谢的减慢或改变、细胞壁厚度的增加、特定分子泵的激活、从细胞外的细胞中清除药物物质有关。同样的机制和其他一些机制也涉及到另一种现象的发展-耐药性,这与分枝杆菌遗传装置的遗传变化有关。本文就结核分枝杆菌与抗结核药物相互作用的分子基础及其流行病学意义作一综述。
{"title":"Molecular bases of the interaction of M. tuberculosis complex and anti-tuberculosis drugs: the current state of the problem and its epidemiological significance","authors":"Yu. S. Khomyakov, D. D. Zvyagintseva, T. Khomyakova","doi":"10.17816/eid312900","DOIUrl":"https://doi.org/10.17816/eid312900","url":null,"abstract":"According to the WHO Global Tuberculosis Report, published in 2022, tuberculosis and its drug-resistant forms are on the rise for the first time in lasted years. The ability to become immune to anti-tuberculosis drugs is a fundamental feature of the TB agent. In some cases, it develops a transient resistance to antibacterial drugs based on a combination of adaptive biological properties of mycobacterium without altering the genetic apparatus. This phenomenon is called drug-induced tolerance. Its development is associated with the slowing or altering of bacterial metabolism, increasing the thickness of the cell wall, activation of specific molecular pumps, removing medicinal substances from the cell outside the cell. The same and some other mechanisms are involved in the development of another phenomenon - drug resistance, which is associated with inherited changes in the genetic apparatus of mycobacterium. The review is devoted to the consideration of the molecular bases of mycobacterium tuberculosis interaction with anti-tuberculosis drugs and its epidemiological significance.","PeriodicalId":93465,"journal":{"name":"Journal of infectious diseases and epidemiology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86067547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Structure and mechanism of action of botulinum and tetanus neurotoxins (literature review) 肉毒杆菌和破伤风神经毒素的结构和作用机制(文献复习)
Pub Date : 2023-04-04 DOI: 10.17816/eid321328
A. Skryabina, Ekaterina S. Golenok, Maxim M. Sobkh, V. Nikiforov
Botulinum neurotoxins (BoNTs) and tetanus neurotoxin (TeNT) are the strongest known toxins which cause neuroparalytic syndromes in botulism and tetanus. The purpose of this review was to systematize the scientific data on the structure and mechanism of action of BoNTs and TeNT. It was established that botulinum and tetanus neurotoxins are proteins containing functional domains responsible for receptor binding, transmembrane translocation, and proteolytic cleavage of proteins required for exocytosis of synaptic vesicles and release of neurotransmitters into the synaptic cleft. The main stages of the BoNTs and TeNT action are described: binding to the presynaptic membrane, internalization of bound toxin into the cytosol via endocytosis, translocation of the L-chain into the cytosol via the HN domain, disruption of the interchain disulfide bond with release of the L-chain to express its catalytic activity (as a metalloprotease) in the cytosol, and selective cleavage of one or more SNARE complex proteins with subsequent blockade of neurotransmitter release.
肉毒杆菌神经毒素(BoNTs)和破伤风神经毒素(TeNT)是已知最强的毒素,可引起肉毒杆菌中毒和破伤风的神经麻痹综合征。本文综述的目的是整理有关BoNTs和TeNT的结构和作用机制的科学资料。已经确定肉毒杆菌和破伤风神经毒素是含有功能域的蛋白质,这些功能域负责受体结合、跨膜易位和突触囊泡胞吐和神经递质释放到突触间隙所需的蛋白质的蛋白水解裂解。本文描述了BoNTs和TeNT作用的主要阶段:与突触前膜结合,结合毒素通过内吞作用内化到细胞质中,l链通过HN结构域转位到细胞质中,破坏链间二硫键并释放l链以表达其在细胞质中的催化活性(作为金属蛋白酶),选择性切割一个或多个SNARE复合蛋白,随后阻断神经递质释放。
{"title":"Structure and mechanism of action of botulinum and tetanus neurotoxins (literature review)","authors":"A. Skryabina, Ekaterina S. Golenok, Maxim M. Sobkh, V. Nikiforov","doi":"10.17816/eid321328","DOIUrl":"https://doi.org/10.17816/eid321328","url":null,"abstract":"Botulinum neurotoxins (BoNTs) and tetanus neurotoxin (TeNT) are the strongest known toxins which cause neuroparalytic syndromes in botulism and tetanus. The purpose of this review was to systematize the scientific data on the structure and mechanism of action of BoNTs and TeNT. It was established that botulinum and tetanus neurotoxins are proteins containing functional domains responsible for receptor binding, transmembrane translocation, and proteolytic cleavage of proteins required for exocytosis of synaptic vesicles and release of neurotransmitters into the synaptic cleft. The main stages of the BoNTs and TeNT action are described: binding to the presynaptic membrane, internalization of bound toxin into the cytosol via endocytosis, translocation of the L-chain into the cytosol via the HN domain, disruption of the interchain disulfide bond with release of the L-chain to express its catalytic activity (as a metalloprotease) in the cytosol, and selective cleavage of one or more SNARE complex proteins with subsequent blockade of neurotransmitter release.","PeriodicalId":93465,"journal":{"name":"Journal of infectious diseases and epidemiology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89487905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Microbial associations in human biotopes as a factor determining the occurrence of polymicrobial infections 人类生物群落中的微生物关联是决定多微生物感染发生的一个因素
Pub Date : 2023-04-03 DOI: 10.17816/eid317442
A. Godovalov
Every year, information is accumulated on the participation of opportunistic microorganisms in the initiation of inflammatory diseases in humans, maintaining a chronic inflammatory response and, thus, adapting to the conditions of existence in the biotopes of the human body. This review provides information on the interactions of microorganisms of medical importance, which affects the virulence of both opportunistic pathogens and classical pathogens, which probably underlies the chronicity of infectious and inflammatory processes. Often, separately opportunistic pathogenic species cannot fully realize their pathogenic potential, which is observed in a greater number of cases under conditions of microbial symbiosis. In general, a revision of approaches to interpreting the results of microbiological methods is required, which involves taking into account the functional activity of the total microflora, as well as the search for individual extrachromosomal genetic elements as a marker of the pathogenicity of a combination of microorganisms.
每年都有关于机会性微生物参与引发人类炎症性疾病、维持慢性炎症反应并因此适应人体生物群落中的生存条件的信息积累。这篇综述提供了具有医学重要性的微生物相互作用的信息,这些相互作用影响机会致病菌和经典致病菌的毒力,这可能是感染和炎症过程的慢性基础。通常,单独的机会致病性物种不能充分发挥其致病潜力,这在微生物共生条件下的更多情况下可以观察到。一般来说,需要对解释微生物学方法结果的方法进行修订,这涉及到考虑到总微生物群的功能活性,以及寻找单个染色体外遗传因子作为微生物组合致病性的标记。
{"title":"Microbial associations in human biotopes as a factor determining the occurrence of polymicrobial infections","authors":"A. Godovalov","doi":"10.17816/eid317442","DOIUrl":"https://doi.org/10.17816/eid317442","url":null,"abstract":"Every year, information is accumulated on the participation of opportunistic microorganisms in the initiation of inflammatory diseases in humans, maintaining a chronic inflammatory response and, thus, adapting to the conditions of existence in the biotopes of the human body. This review provides information on the interactions of microorganisms of medical importance, which affects the virulence of both opportunistic pathogens and classical pathogens, which probably underlies the chronicity of infectious and inflammatory processes. Often, separately opportunistic pathogenic species cannot fully realize their pathogenic potential, which is observed in a greater number of cases under conditions of microbial symbiosis. In general, a revision of approaches to interpreting the results of microbiological methods is required, which involves taking into account the functional activity of the total microflora, as well as the search for individual extrachromosomal genetic elements as a marker of the pathogenicity of a combination of microorganisms.","PeriodicalId":93465,"journal":{"name":"Journal of infectious diseases and epidemiology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85831528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Journal of infectious diseases and epidemiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1